UBS analyst Jay Sole upgraded TJX to Neutral from Sell and raised his price target for the shares to $58 from $41. Tariffs will likely drive incremental market share gains for the company, while UBS Evidence Lab market research shows consumers continue to prioritize TJX's value-for-money offering over other retailers' strategies, Sole tells investors in a research note. The analyst, who raised his fiscal 2019 and 2020 earnings by estimates 3% and 12%, respectively, believes share gains will likely mean that TJX should be able to maintain its premium valuation.